Two novel cases of compound heterozygous mutations in mitofusin2: Finding out the inheritance

Neuromuscul Disord. 2017 Apr;27(4):377-381. doi: 10.1016/j.nmd.2017.01.010. Epub 2017 Jan 17.


MFN2 is the major gene involved in the axonal form of Charcot-Marie-Tooth disease. It usually has an autosomal dominant pattern of inheritance, but a few cases of homozygous or compound heterozygous mutations have been described. These patients usually present an earlier onset, more severe phenotype and their inheritance pattern can span from autosomal recessive to semidominant. Here we report two unrelated patients carrying two compound heterozygous MFN2 mutations. Both present a pure axonal neuropathy without any additional features. The first patient presents a mild clinical phenotype with onset in the 2nd decade, while the second patient shows a severe, early onset phenotype with loss of independent ambulation. Only a careful clinical examination as well as neurophysiological and genetic studies allowed us to establish the role and the transmission pattern of the identified variants. We discuss practical consequences of this finding in genetic counseling.

Keywords: CMT2; Compound heterozygosity; Genetic counseling; Inheritance; MFN2.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Charcot-Marie-Tooth Disease / genetics*
  • Female
  • GTP Phosphohydrolases / genetics*
  • Humans
  • Mitochondrial Proteins / genetics*
  • Pedigree


  • Mitochondrial Proteins
  • GTP Phosphohydrolases
  • MFN2 protein, human